Cleviprex

Active Ingredient(s): Clevidipine Butyrate
FDA Approved: * August 1, 2008
Pharm Company: * MEDICINES CO
Category: Blood Pressure

Clevidipine (INN,[2] trade name Cleviprex) is a dihydropyridine calcium channel blocker indicated for the reduction of blood pressure when oral therapy is not feasible or not desirable. Clevidipine is used IV only and practitioners titrate this drug to lower blood pressure. It has a half-life of approximately one minute. It is rapidly inactivated by esterases. It was approved by the United States Food and Drug Administration on August 1, 2008. Contents 1 Basic chemical and ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Cleviprex .5 mg/ml Intravenous Emulsion
NDC: 10122-610
Labeler:
Chiesi USA, Inc.
Cleviprex .5 mg/ml Intravenous Emulsion
NDC: 10122-611
Labeler:
Chiesi USA, Inc.
Cleviprex .5 mg/ml Intravenous Emulsion
NDC: 10122-612
Labeler:
Chiesi USA, Inc.
Cleviprex .5 mg/ml Intravenous Emulsion
NDC: 18124-011
Labeler:
Fresenius Kabi Austria Gmbh
Cleviprex .5 mg/ml Intravenous Emulsion
NDC: 65293-005
Labeler:
The Medicines Company